BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25448881)

  • 1. Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer.
    Liao A; Wang W; Sun D; Jiang Y; Tian S; Li J; Yang X; Shi R
    Tumour Biol; 2015 Apr; 36(4):2773-8. PubMed ID: 25448881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer.
    Yang Y; Yang C; Zhang J
    Med Oncol; 2015 Mar; 32(3):76. PubMed ID: 25698539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma.
    Lv B; Yang X; Lv S; Wang L; Fan K; Shi R; Wang F; Song H; Ma X; Tan X; Xu K; Xie J; Wang G; Feng M; Zhang L
    Mol Neurobiol; 2015 Dec; 52(3):1263-1268. PubMed ID: 25326893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas.
    Yu H; Zhang L; Liu P
    Tumour Biol; 2015 Mar; 36(3):1679-83. PubMed ID: 25359618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-OH-BDE-47 promotes human lung cancer cells epithelial mesenchymal transition via the AKT/Snail signal pathway.
    Qu BL; Yu W; Huang YR; Cai BN; Du LH; Liu F
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):271-9. PubMed ID: 25531265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3β signaling in gastric cancer.
    Dai J; Qian C; Su M; Chen M; Chen J
    Tumour Biol; 2016 Sep; 37(9):12403-12410. PubMed ID: 27323966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways.
    Cui Y; Wang Y; Li H; Li Q; Yu Y; Xu X; Xu B; Liu T
    Oncotarget; 2016 Jun; 7(23):34356-70. PubMed ID: 27102302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.
    Huang N; Wu Z; Lin L; Zhou M; Wang L; Ma H; Xia J; Bin J; Liao Y; Liao W
    Oncotarget; 2015 Jun; 6(17):15222-34. PubMed ID: 25945841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
    Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion.
    Kang MH; Kang HN; Kim JL; Kim JS; Oh SC; Yoo YA
    Oncol Rep; 2009 Sep; 22(3):525-34. PubMed ID: 19639199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR7 pathway induces epithelial-mesenchymal transition through up-regulation of Snail signaling in gastric cancer.
    Zhang J; Zhou Y; Yang Y
    Med Oncol; 2015 Feb; 32(2):467. PubMed ID: 25572817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.